On June 5, 2018 bluebird bio, Inc. (Nasdaq: BLUE) reported that members of the management team will present at the following upcoming investor conferences in June (Press release, bluebird bio, JUN 5, 2018, View Source [SID1234527175]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies Global Healthcare Conference, Thursday, June 7, at 10:00 a.m. ET at the Grand Hyatt, New York City.

Goldman Sachs Global Healthcare Conference, Tuesday, June 12, at 11:20 a.m. PT at the Terranea Resort, Rancho Palos Verdes, California.

As previously announced, the Company will also host a conference call to review data being presented at the Annual Congress of the European Hematology Association (EHA) (Free EHA Whitepaper):

EHA Data Review Conference Call, Friday, June 15, 8:00 a.m. EST. Investors may listen to the call by dialing (844) 825-4408 from locations in the United States or +1 (315) 625-3227 from outside the United States. Please refer to conference ID number 4678706.
To access the live webcasts of bluebird bio’s presentations and conference calls, please visit the "Events & Presentations" page within the Investors and Media section of the bluebird bio website at View Source Replays of the webcasts will be available on the bluebird bio website for 90 days following the events.